US FDA Archives - Express Pharma

Granules India’s Gagillapur facility classified as “Official Action Indicated” following US FDA Inspection

Lupin receives tentative U.S. FDA approval for Raltegravir tablets

Alembic secures USFDA approval for Diltiazem Hydrochloride extended-release capsules

US FDA approves Eli Lilly’s drug for eczema

FDA issues warning letters to two Chinese firms over data integrity concerns

Lupin receives U.S. FDA approval for Brimonidine Tartrate Ophthalmic Solution

US FDA approves AstraZeneca’s non-small cell lung cancer treatment

Atul Bioscience receives US FDA EIR with zero observations for Ambernath facility

Dr Reddy’s Labs gets US FDA clearance: Visakhapatnam facilities classified as VAI

Granules India gains ANDA approval for Trazodone tablets